BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33407484)

  • 1. Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy.
    Chung H; Kim Y; Park CH; Kim IS; Kim JY; Min PK; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Lee KA; Choi EY
    Cardiovasc Ultrasound; 2021 Jan; 19(1):4. PubMed ID: 33407484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Farhad H; Seidelmann SB; Vigneault D; Abbasi SA; Yang E; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Jerosch-Herold M; Bluemke DA; Ho C; Neilan TG
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):107. PubMed ID: 29284499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
    Papavassiliu T; Germans T; Flüchter S; Doesch C; Suriyakamar A; Haghi D; Süselbeck T; Wolpert C; Dinter D; Schoenberg SO; van Rossum AC; Borggrefe M
    J Cardiovasc Magn Reson; 2009 Sep; 11(1):34. PubMed ID: 19740409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.
    Zhu Y; Park EA; Lee W; Kim HK; Chu A; Chung JW; Park JH
    Eur Radiol; 2015 Apr; 25(4):1190-200. PubMed ID: 25597022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.
    Fujimoto K; Inoue K; Saito M; Higashi H; Kono T; Uetani T; Aono J; Nagai T; Nishimura K; Suzuki J; Okura T; Ikeda S; Nakatani S; Higaki J
    Echocardiography; 2018 Aug; 35(8):1138-1148. PubMed ID: 29648690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
    Ozden O; Unlu S; Kilic DI; Sherif SA; Opan S; Kemal HS; Ozmen E; Tuner H; Bingol G; Barutcu A; Nasifov M; Bakan S; Goktekin O
    Kardiologiia; 2023 Feb; 63(2):52-58. PubMed ID: 36880144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy.
    Kim KJ; Choi HM; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Zo JH; Sohn DW
    PLoS One; 2016; 11(6):e0157433. PubMed ID: 27336444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between left atrial myopathy and sarcomere mutation in patients with hypertrophic cardiomyopathy: insights into left atrial strain by MRI feature tracking.
    Wang J; Ma X; Zhao K; Yang S; Yang K; Yu S; Yin G; Dong Z; Song Y; Cui C; Li J; Zhao S; Chen X
    Eur Radiol; 2024 Feb; 34(2):1026-1036. PubMed ID: 37635167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of left atrial function in patients with hypertrophic obstructive cardiomyopathy before and 1 year after septal ablation by two-dimensional speckle tracking echocardiography.
    Fang H; Tang H; Li P; Xiong L; Hu G; Li L; Yu Y; Zhao B
    Echocardiography; 2017 Mar; 34(3):407-414. PubMed ID: 28130861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.
    Sivalokanathan S; Zghaib T; Greenland GV; Vasquez N; Kudchadkar SM; Kontari E; Lu DY; Dolores-Cerna K; van der Geest RJ; Kamel IR; Olgin JE; Abraham TP; Nazarian S; Zimmerman SL; Abraham MR
    JACC Clin Electrophysiol; 2019 Mar; 5(3):364-375. PubMed ID: 30898240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.
    Yang Y; Yin G; Jiang Y; Song L; Zhao S; Lu M
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):1. PubMed ID: 31898543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy.
    Hinojar R; Zamorano JL; Fernández-Méndez M; Esteban A; Plaza-Martin M; González-Gómez A; Carbonell A; Rincón LM; Nácher JJJ; Fernández-Golfín C
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1055-1065. PubMed ID: 30706353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
    Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.
    Germans T; Rüssel IK; Götte MJ; Spreeuwenberg MD; Doevendans PA; Pinto YM; van der Geest RJ; van der Velden J; Wilde AA; van Rossum AC
    J Cardiovasc Magn Reson; 2010 Mar; 12(1):13. PubMed ID: 20230637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Interstitial fibrosis is associated with left atrial remodeling and adverse clinical outcomes in selected low-risk patients with hypertrophic cardiomyopathy".
    Tondi L; Pica S; Crimi G; Disabato G; Figliozzi S; Camporeale A; Bernardini A; Tassetti L; Milani V; Piepoli MF; Lombardi M
    Int J Cardiol; 2024 Aug; 408():132135. PubMed ID: 38705206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of left atrial reservoir function with left atrial structural remodeling related to left ventricular dysfunction in asymptomatic patients with hypertension: evaluation by two-dimensional speckle-tracking echocardiography.
    Miyoshi H; Oishi Y; Mizuguchi Y; Iuchi A; Nagase N; Ara N; Oki T
    Clin Exp Hypertens; 2015; 37(2):155-65. PubMed ID: 25050647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of left atrial function in patients with hypertrophic cardiomyopathy using two-dimensional strain: a comparison with volume-derived values.
    Huang J; Yan ZN; Rui YF; Fan L; Shen D; Chen DL
    Minerva Cardioangiol; 2018 Feb; 66(1):26-37. PubMed ID: 28752727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Chung H; Kim Y; Park CH; Kim JY; Min PK; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Lee KA; Choi EY
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):18. PubMed ID: 33658040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic determinants of left atrial strain in patients with hypertrophic cardiomyopathy: A combined echocardiography and CMR study.
    Tayal B; Malahfji M; Buergler JM; Shah DJ; Nagueh SF
    PLoS One; 2021; 16(2):e0245934. PubMed ID: 33566865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.